← Evidence library

BIB_393

Chang et al. 2026 JNCCN — GLP-1 / dual agonists and skin-cancer incidence: RCT meta-analysis (15 RCTs, n=73,412) shows NO significant effect on melanoma or keratinocyte cancers. Patient-relevant: removes a theoretical barrier to GLP-1 weight-management therapy, which targets this patient's DOMINANT modifiable (CV/metabolic competing) risk.

Evidence grade

B

Tier

1 (JNCCN, peer-reviewed; RCT meta-analysis n=73,412; abstract-level — JNCCN full

Cited by tasks

11, 12, 25

Identifiers

PMC12371547 · DOI:10.6004/jnccn · PMID:42066808

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_393/findings.md (research corpus). This page is a short context summary — not individualised medical advice.